Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease

Journal of Pediatrics

Volumn 140, Issue 6, 2002, Pages 742-746

  Leung, Donald Y M ^{a,b,c,d,e,f,g,h,i}   Meissner, H Cody ^{a,b,c,d,e,f,g,h,i}   Shulman, Stanford T ^{a,b,c,d,e,f,g,h,i}   Mason, Wilbert H ^{a,b,c,d,e,f,g,h,i}   Gerber, Michael A ^{a,b,c,d,e,f,g,h,i}   Glode, Mary P ^{a,b,c,d,e,f,g,h,i}   Myones, Barry L ^{a,b,c,d,e,f,g,h,i}   Wheeler, J Gary ^{a,b,c,d,e,f,g,h,i}   Ruthazer, Robin ^{a,b,c,d,e,f,g,h,i}   Schlievert, Patrick M ^{a,b,c,d,e,f,g,h,i}  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b CHILDREN S HOSPITAL   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

^h ARKANSAS CHILDREN S HOSPITAL   (United States)

ⁱ UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; SUPERANTIGEN;

ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; INFANT; MUCOCUTANEOUS LYMPH NODE SYNDROME; MULTICENTER STUDY; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS;

EID: 0036085255     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2002.123664     Document Type: Article

References (30)

1. A nationwide survey of Kawasaki disease and acute rheumatic fever
2. Long-term cardiac sequelae of Kawasaki disease
3. Long term consequences of regressed coronary aneurysms after Kawasaki disease: Vascular wall morphology and function
4. The etiology and pathogenesis of Kawasaki disease: How close are we to an answer?
5. Superantigens, conventional antigens and etiology of Kawasaki syndrome
6. The immunopathogenesis and management of Kawasaki syndrome
7. Superantigens and their potential role in human disease
8. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome
9. Kawasaki syndrome is not caused by toxic shock syndrome toxin-1+ Staphylococci
10. The absence of evidence of staphylococcal toxin involvement in the parhogenesis of Kawasaki disease
11. Diagnostic guidelines for Kawasaki disease
12. Toxin and enzyme characterization of Staphylococcus aureus isolates from patients with and without toxic shock syndrome
13. Quantification and toxicity of group A streptococcal pyrogenic exotoxins in an animal model of toxic shock syndrome-like illness
14. Immunochemical assays for toxic shock syndrome toxin-1
15. The selective expansion of T cells expressing Vβ2 and Vβ8 in Kawasaki disease
16. Characterization of T cell repertoire changes in acute Kawasaki disease
17. Evidence for a superantigen mediated process in Kawasaki disease
18. Selective increase of Vβ2+ T cells in the small intestinal mucosa in Kawasaki disease
19. Polyclonal expansion of TCRβV2- and TCRβV6-bearing T cells in patients with Kawasaki disease
20. Evidence for superantigen involvement in cardiovascular injury due to Kawasaki syndrome
21. TCR Vβ family repertoire and T cell activation markers in Kawasaki disease
22. Clonal expansion of CD8+ T cells in Kawasaki disease
23. Characterization of CD4+ T helper cells in patients with Kawasaki disease (KD): Preferential production of tumor necrosis factor-alpha (TNF-alpha) by Vβ 2- or Vβ 8- CD4+ T helper cells
24. Psoriatic eruption in Kawasaki disease
25. A case of guttate psoriasis following Kawasaki disease
26. Pulling the trigger on psoriasis
27. Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis
28. Increased prevalence of atopic dermatitis in Kawasaki disease
29. Application of staphylococcal enterotoxin B on normal and atopic skin induces upregulation of T cells via a superantigen-mediated mechanism
30. Atopic dermatitis and staphylococcal superantigens